Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

Marco Zecca, Piero De Stefano, Bruno Nobili, Franco Locatelli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences